{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:27:25Z","timestamp":1790861245267,"version":"4.1.0"},"reference-count":63,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4422,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["MH-15144"],"award-info":[{"award-number":["MH-15144"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["DA-00482"],"award-info":[{"award-number":["DA-00482"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress. Anxiety"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1002\/da.10096","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T10:15:27Z","timestamp":1059646527000},"page":"29-40","source":"Crossref","is-referenced-by-count":139,"title":["Pharmacological treatment of social anxiety disorder: A meta-analysis"],"prefix":"10.1155","volume":"18","author":[{"given":"Carlos","family":"Blanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin R.","family":"Schneier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen-Rosa","family":"Blanco-Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall D.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"S\u00e1nchez-Lacay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Liebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2003,7,24]]},"reference":[{"key":"10.1002\/da.10096-BIB1|cit3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0447.1999.tb10845.x","article-title":"Paroxetine in social anxiety disorder: A randomized placebo-controlled study","volume":"100","author":"Allgulander","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1002\/da.10096-BIB2|cit4","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/da.10096-BIB3|cit5","first-page":"1045","article-title":"Beta-blocker therapy for congestive heart failure: A systematic overview and critical appraisal of the published trials","volume":"14","author":"Avezum","year":"1998","journal-title":"Can J Cardiol"},{"key":"10.1002\/da.10096-BIB4|cit6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.175.2.120","article-title":"Paroxetine in social phobia\/social anxiety disorder: Randomized, double-blind, placebo-controlled study","volume":"175","author":"Baldwin","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.10096-BIB5|cit7","first-page":"339","volume-title":"The handbook of research synthesis","author":"Begg","year":"1994"},{"key":"10.1002\/da.10096-BIB6|cit8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-3223(01)01294-X","article-title":"Pharmacological treatment of social anxiety disorder","volume":"51","author":"Blanco","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.10096-BIB7|cit9","first-page":"491","volume-title":"Design and analysis of clinical trials","author":"Chow","year":"1998"},{"key":"10.1002\/da.10096-BIB8|cit10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00004714-199810000-00004","article-title":"Discontinuation of clonazepam in the treatment of social phobia","volume":"18","author":"Connor","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB9|cit11","first-page":"47","article-title":"harmacotherapy of social anxiety disorder","volume":"59","author":"Davidson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.10096-BIB10|cit12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199312000-00008","article-title":"Treatment of social phobia with clonazepam and placebo","volume":"13","author":"Davidson","year":"1993b","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB11|cit13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02190409","article-title":"Recent developments in the psychopharmacology of social phobia","volume":"244","author":"den Boer","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1002\/da.10096-BIB12|cit14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimmonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1002\/da.10096-BIB13|cit15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0895-4356(92)90085-2","article-title":"Incorporating variations in the quality of individual randomized trials into meta-analysis","volume":"45","author":"Detsky","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/da.10096-BIB14|cit16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0447.1995.tb09596.x","article-title":"Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine","volume":"92","author":"Fahlen","year":"1995","journal-title":"Acta Psychiatr Scand"},{"key":"10.1002\/da.10096-BIB15|cit17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-200106000-00011","article-title":"Psychological and pharmacological treatments of social phobia: A meta-analysis","volume":"21","author":"Fedoroff","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB16|cit18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0005-7894(05)80040-1","article-title":"Cognitive-behavioral versus exposure only treatment for social phobia: A meta-analysis","volume":"23","author":"Feske","year":"1995","journal-title":"Behav Ther"},{"key":"10.1002\/da.10096-BIB17|cit19","first-page":"245","volume-title":"The handbook of research synthesis","author":"Fleiss","year":"1994"},{"key":"10.1002\/da.10096-BIB18|cit20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archpsyc.1991.01810340070009","article-title":"Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study","volume":"48","author":"Gelernter","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10096-BIB19|cit21","first-page":"339","volume-title":"The handbook of research synthesis","author":"Gleser","year":"1994"},{"key":"10.1002\/da.10096-BIB20|cit22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1468-2850.1997.tb00123.x","article-title":"Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis","volume":"4","author":"Gould","year":"1997","journal-title":"Clin Psychol Sci Pract"},{"key":"10.1002\/da.10096-BIB21|cit23","first-page":"383","volume-title":"The handbook of research synthesis","author":"Greenhouse","year":"1994"},{"key":"10.1002\/da.10096-BIB22|cit24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2307\/2528104","article-title":"The two-period change-over design and its use in clinical trials","volume":"21","author":"Grizzle","year":"1965","journal-title":"Biometrics"},{"key":"10.1002\/da.10096-BIB23|cit25","doi-asserted-by":"crossref","unstructured":"Guy W 1976 ECDEU Assessment manual for psychopharmacology 217 222","DOI":"10.1037\/e591322011-001"},{"key":"10.1002\/da.10096-BIB24|cit26","volume-title":"Statistical methods for meta-analysis","author":"Hedges","year":"1985"},{"key":"10.1002\/da.10096-BIB25|cit27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/S0033291798007879","article-title":"Psychometric properties of the Liebowitz Social Anxiety Scale","volume":"29","author":"Heimberg","year":"1999","journal-title":"Psychol Med"},{"key":"10.1002\/da.10096-BIB26|cit28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","article-title":"Cognitive-behavioral group therapy versus phenelzine in social phobia: 12-week outcome","volume":"55","author":"Heimberg","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10096-BIB27|cit29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S1461145701002504","article-title":"Social anxiety disorder in review: Two decades of progress","volume":"4","author":"Hidalgo","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/da.10096-BIB28|cit30","volume-title":"Methods of meta-analysis: Correcting errors and bias in research findings","author":"Hunter","year":"1990"},{"key":"10.1002\/da.10096-BIB29|cit31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/070674379604101002","article-title":"Antidepressant treatment of depression: A meta-analysis","volume":"41","author":"Joffe","year":"1996","journal-title":"Can J Psychiatry"},{"key":"10.1002\/da.10096-BIB30|cit32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02900196","article-title":"Moclobemide in social phobia: A double-blind, placebo-controlled clinical study","volume":"247","author":"Katschnig","year":"1997","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1002\/da.10096-BIB31|cit33","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1176\/ajp.152.9.1368","article-title":"Sertraline for social phobia: A double-blind, placebo-controlled crossover study","volume":"152","author":"Katzelnick","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10096-BIB32|cit34","first-page":"2432","volume-title":"Kaplan & Sadock's comprehensive textbook of psychiatry","author":"Kelsey","year":"2000"},{"key":"10.1002\/da.10096-BIB33|cit35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1037\/0022-006X.63.5.702","article-title":"Issues in the transportability of treatment: The case of anxiety disorders in youths","volume":"63","author":"Kendall","year":"1995","journal-title":"J Cons Clin Psychol"},{"key":"10.1002\/da.10096-BIB34|cit36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1002\/da.10096-BIB35|cit37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1002\/da.10096-BIB36|cit38","first-page":"252","article-title":"Pharmacotherapy of social phobia: An interim report of a placebo-controlled comparison of phenelzine and atenolol","volume":"47","author":"Liebowitz","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.10096-BIB37|cit39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","article-title":"Phenelzine versus atenolol in social phobia: A placebo-controlled comparison","volume":"49","author":"Liebowitz","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10096-BIB38|cit40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004714-199708000-00003","article-title":"Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study","volume":"17","author":"Lott","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB39|cit41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-199708000-00002","article-title":"Moclobemide in social phobia: A controlled dose-response trial","volume":"17","author":"Noyes","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB40|cit42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004850-199606003-00013","article-title":"Moclobemide in the treatment of social phobia","volume":"11","author":"Nutt","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB41|cit43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0327(98)00093-7","article-title":"Implications of the severity of social phobia","volume":"50","author":"Montgomery","year":"1998","journal-title":"J Affect Dis"},{"key":"10.1002\/da.10096-BIB42|cit44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","article-title":"Treatment of social phobia with gabapentin: A placebo-controlled study","volume":"19","author":"Pande","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.10096-BIB43|cit45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","article-title":"Cumulative evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis","volume":"18","author":"Pogue","year":"1997","journal-title":"Controlled Clin Trials"},{"key":"10.1002\/da.10096-BIB44|cit46","volume-title":"Meta-analytic procedures for social research","author":"Rosenthal","year":"1984"},{"key":"10.1002\/da.10096-BIB45|cit47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1192\/bjp.172.1.70","article-title":"A placebo-controlled trial of moclobemide in social phobia","volume":"172","author":"Schneier","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.10096-BIB46|cit48","first-page":"1453","volume-title":"Treatment of Psychiatric Disorders, 2nd edition","author":"Schneier Marshall","year":"1995"},{"key":"10.1002\/da.10096-BIB47|cit49","first-page":"402","article-title":"A double-blind placebo-controlled trial of paroxetine in management of social phobia (social anxiety disorder) in South Africa","volume":"89","author":"Stein","year":"1999","journal-title":"S Afr Med J"},{"key":"10.1002\/da.10096-BIB48|cit50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archpsyc.58.3.251","article-title":"Social anxiety disorder and the risk for depression: A prospective community study of adolescents and young adults","volume":"58","author":"Stein","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10096-BIB49|cit51","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1176\/appi.ajp.157.10.1606","article-title":"Disability and quality of life in social phobia: Epidemiological findings","volume":"157","author":"Stein","year":"2000a","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10096-BIB50|cit52","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archpsyc.57.11.1046","article-title":"Social phobia symptoms, subtypes, and severity","volume":"57","author":"Stein","year":"2000b","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.10096-BIB51|cit53","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","article-title":"Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized, double-blind, placebo-controlled study","volume":"280","author":"Stein","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/da.10096-BIB52|cit54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.156.5.756","article-title":"Fluvoxamine treatment so social phobia (social anxiety disorder): A double-blind, placebo- controlled study","volume":"156","author":"Stein","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10096-BIB53|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7916(95)00058-5","article-title":"Meta-analysis of cognitive-behavioral treatments for social phobia","volume":"27","author":"Taylor","year":"1996","journal-title":"J Beahv Ther Exp Psychiatry"},{"key":"10.1002\/da.10096-BIB54|cit56","first-page":"219","volume-title":"Textbook of psychopharmacology","author":"Tollefson","year":"1998"},{"key":"10.1002\/da.10096-BIB55|cit57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1037\/0022-006X.62.2.350","article-title":"Social phobia: A comparison of behavior therapy and atenolol","volume":"62","author":"Turner","year":"1994","journal-title":"J Cons Clin Psychology"},{"key":"10.1002\/da.10096-BIB56|cit58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1176\/appi.ajp.158.2.275","article-title":"Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study","volume":"158","author":"Van Ameringen","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.10096-BIB57|cit59","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00004850-200008002-00004","article-title":"The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): A meta-analysis of randomized controlled trials","volume":"15","author":"van der Linden","year":"2000","journal-title":"Int Clin Psychopharm."},{"key":"10.1002\/da.10096-BIB58|cit60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0924-977X(92)90032-4","article-title":"Psychopharmacological treatment of social phobia: Clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor","volume":"2","author":"van Vliet","year":"1992","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/da.10096-BIB59|cit61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02244762","article-title":"Psychopharmacological treatment of social phobia: A double blind controlled study with fluvoxamine","volume":"115","author":"van Vliet","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.10096-BIB60|cit62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4088\/JCP.v58n0405","article-title":"Clinical effects of buspirone in social phobia: A double-blind placebo-controlled study","volume":"58","author":"van Vliet","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.10096-BIB61|cit63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1192\/bjp.161.3.353","article-title":"Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine","volume":"161","author":"Versiani","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.10096-BIB62|cit64","first-page":"167","article-title":"Double-blind placebo controlled trial with bromazepam in social phobia","volume":"46","author":"Versiani","year":"1997","journal-title":"J Brasil Psiquiatria"},{"key":"10.1002\/da.10096-BIB63|cit65","doi-asserted-by":"crossref","DOI":"10.4135\/9781412984980","volume-title":"Meta-analysis: Quantitative methods for research synthesis","author":"Wolf","year":"1986"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.10096","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/da.10096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T10:25:43Z","timestamp":1704882343000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.10096"}},"subtitle":["Research Article: Meta-Analysis of Social Anxiety Disorder"],"short-title":[],"issued":{"date-parts":[[2003,7,24]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,8]]}},"URL":"https:\/\/doi.org\/10.1002\/da.10096","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7,24]]}}}